Actavis divests its distribution business in Bulgaria
Actavis has announced the divestment of its Bulgarian distribution company, Higia EAD, to a local private investor, Rossitsa Veselinova Velikova.
This decision is a result of the detailed business review conducted on global and local level in 2009. Actavis continues to focus its efforts on its core business, the development, production and sale of high-quality generic pharmaceuticals.
Iliya Pashov, Executive director of Actavis Bulgaria: “Actavis is the biggest pharmaceutical company in Bulgaria in terms of sales and production. Our future plans are to focus on Actavis’ core business and that does not include distribution. Among a number of offers received we chose the best one, not only for Actavis but for the employees of Higia and its future growth on the local distribution market. Actavis will continue working with Higia and the other pharmaceutical distributors in Bulgaria.”
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.